Likewise, TNFRSF1A expression of gliomas carrying 1p/19q codeletion or IDH mutation was lower than the corresponding glioma samples (Figures 4Q–V; Supplementary Tables 1–3). This evidence concerns the gene TNFRSF1A and central nervous system cancer.